Black Diamond Therapeutics

BDTX

Market cap $138M

2.43 USD

-0.04

1.62%

At close Updated Mar 2, 4:00 PM EST

Pre-market

After hours

2.34

-0.09

3.7%

1 day

-1.62%

5 days

0.83%

1 month

-4.33%

3 months

-29.57%

6 months

-13.21%

Year to date

-2.41%

1 year

27.23%

5 years

-90.86%

10 years

-93.84%

About: Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Employees: 54

Healthcare Biotechnology